Lymfactin® gene therapy with vascularized lymph node transfer reduces compression-free swelling and enhances quality of life in breast cancer-related lymphedema: Final Phase I trial results
Open Access
- 16 October 2025
- journal article
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 111, 312-321
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Orthotopic vascularized lymph node transfer in breast cancer‐related lymphedema treatment: Functional and life quality outcomesMicrosurgery, 2024
- Global Stage Distribution of Breast Cancer at DiagnosisJAMA Oncology, 2024
- Phase 1 Lymfactin® Study: 24-month Efficacy and Safety Results of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity LymphedemaJournal of Plastic, Reconstructive & Aesthetic Surgery, 2022
- Phase 1 LymfactinⓇ Study: Short-term Safety of Combined Adenoviral VEGF-C and Lymph Node Transfer Treatment for Upper Extremity LymphedemaJournal of Plastic, Reconstructive & Aesthetic Surgery, 2020
- Free vascularized lymph node transfer for treatment of lymphedema: A systematic evidence based reviewJournal of Plastic, Reconstructive & Aesthetic Surgery, 2016
- Growth factor therapy and lymph node graft for lymphedemaJournal of Surgical Research, 2015
- VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal studyAngiogenesis, 2015
- Risk of donor-site lymphatic vessel dysfunction after microvascular lymph node transferJournal of Plastic, Reconstructive & Aesthetic Surgery, 2015
- Free lymph node flap transfer and laser-assisted liposuction: a combined technique for the treatment of moderate upper limb lymphedemaLasers in Medical Science, 2015
- Lymphedema following breast cancer treatment and impact on quality of life: A reviewCritical Reviews in Oncology/Hematology, 2014